BeOne Medicines (BEIGF) Shares Outstanding (Weighted Average) (2015 - 2020)

BeOne Medicines (BEIGF) has 5 years of Shares Outstanding (Weighted Average) data on file, last reported at $1.0 billion in Q1 2020.

• Shares Outstanding (Weighted Average) for Q1 2020 came in at $1.0 billion, changed N/A year-over-year; the trailing twelve-month figure through Mar 2020 was $1.0 billion (changed N/A YoY), and the FY2018 annual result was $720.8 million, up 32.69% from the prior year.
• Shares Outstanding (Weighted Average) advanced to $1.0 billion in Q1 2020 per BEIGF's latest filing, from $720.8 million in the prior quarter.
• Over five years, Shares Outstanding (Weighted Average) peaked at $1.0 billion in Q1 2020 and troughed at $294.0 million in Q1 2016.
• A 4-year average of $557.9 million and a median of $522.5 million in 2017 frame the typical range for Shares Outstanding (Weighted Average).
• The sharpest annual moves came in 2016 and 2017: Shares Outstanding (Weighted Average) soared 294.07% in 2016, then rose 21.02% in 2017.
• A 4-year view of Shares Outstanding (Weighted Average) shows it stood at $403.6 million in 2016, then jumped by 34.58% to $543.2 million in 2017, then jumped by 32.69% to $720.8 million in 2018, then jumped by 39.49% to $1.0 billion in 2020.
• Business Quant data shows BEIGF's Shares Outstanding (Weighted Average) at $1.0 billion in Q1 2020, $720.8 million in Q4 2018, and $684.6 million in Q2 2018.